Open AccessUse of four‐factor prothrombin complex concentrate for the mitigation of rivaroxaban‐induced bleeding in an emergent coronary artery bypass graft
Author(s) -
Liu Michael,
Aguele Cliff,
Darr Umer
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.790
Subject(s) - medicine , rivaroxaban , prothrombin complex concentrate , artery , cardiology , major bleeding , warfarin , surgery , atrial fibrillation
Key Clinical Message We presented the first case of four‐factor prothrombin complex concentrate (4F‐ PCC ) for the alleviation of bleeding for emergent on‐pump coronary artery bypass graft (CABG) with the patient discharged by postoperative day (POD) 9 with no sequelae. Until direct antidotes are available, 4F‐ PCC may play a role in the management of mitigating rivaroxaban‐induced bleeding in surgical procedure.